Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
226.00
-55 (-19.57%)
BSENSE

Mar 24

BSE+NSE Vol: 93.01 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BDH Industries
Medico Remedies
Trident Lifeline
Zenotech Lab.
Gennex Lab.
Everest Organics
Bafna Pharma.
Valiant Laborato
Aptus Pharma
Sat Kartar
Infinium Pharma

Why is Everest Organics Ltd ?

1
Weak Long Term Fundamental Strength with a -12.16% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.46 times
  • The company has been able to generate a Return on Equity (avg) of 5.58% signifying low profitability per unit of shareholders funds
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Everest Organics for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Everest Organics
-7.85%
-0.13
59.18%
Sensex
-5.02%
-0.39
12.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.60%
EBIT Growth (5y)
-12.16%
EBIT to Interest (avg)
0.75
Debt to EBITDA (avg)
15.01
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
1.89
Tax Ratio
14.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
1.12%
ROE (avg)
5.58%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
38
Industry P/E
31
Price to Book Value
3.03
EV to EBIT
25.70
EV to EBITDA
16.19
EV to Capital Employed
2.22
EV to Sales
1.42
PEG Ratio
0.17
Dividend Yield
NA
ROCE (Latest)
9.06%
ROE (Latest)
8.05%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
NET SALES(9M)

At Rs 147.40 cr has Grown at 24.34%

ROCE(HY)

Highest at 9.86%

PAT(9M)

Higher at Rs 2.93 Cr

DEBT-EQUITY RATIO(HY)

Lowest at 0.68 times

-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 1.63 times

NET SALES(Q)

At Rs 42.59 cr has Fallen at -9.3% (vs previous 4Q average

EPS(Q)

Lowest at Rs 0.37

Loading Valuation Snapshot...

Here's what is working for Everest Organics

Profit After Tax (PAT) - Nine Monthly
At Rs 2.93 cr has Grown at 169.60%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.68 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Profit After Tax (PAT) - Nine Monthly
Higher at Rs 2.93 Cr
than preceding 12 month period ended Dec 2025 of Rs -1.30 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)

Here's what is not working for Everest Organics

Net Sales - Quarterly
At Rs 42.59 cr has Fallen at -9.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 46.95 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.37
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Lowest at 1.63 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio